Gene therapy for foxg1 syndrome

Abstract

Provided herein are expression constructs and viral vectors for use as gene therapies for FOXG1 haploinsufficiency. In various aspects, the expression constructs comprise a FOXG1 encoding nucleic acid and one or more miRNA regulatory elements that limit overexpression in vivo.